Keynote
Sessions
The following topics
will be covered in this session:
- Strategic Overview: Understand the major drivers
that are going to effect pharma's business model over the next 10 years
- Understand what the pharma New Commercial Model needs
to look like to counteract current and future challenges and ensure
profitability and shareholder value
- Hear how other industry's have changed their business models
and what impact this has had on their profits
- New Customers, new influencers and tighter regulations – how do you
change your sales and marketing activities to engage customers
and impact sales results?
- How to improve image, reputation and value through
your sales and marketing activities and how this will impact your sales
- The Empowered Patient and what this means for your
business
- Emerging Markets – Understand the opportunities and
how to structure your organization to maximize their potential
Confirmed speakers for this
session:
 |
Reinhard Angelmar,
The Salmon and Rameau Fellow in Healthcare Management and Professor
of Marketing INSEAD |
 |
Patrick Cheron,
Head of CRM Center of Excellence Region Europe & EGM
Novartis |
 |
Leandro Herrero,
CEO The Chalfont Project |
 |
Roland Powell
Former European Director of Marketing & Sales Capabilities
Eli Lilly & Company |
|
 |
Graham Stevenson
Head of European SFE Celgene |
 |
Penny Stobbs
Senior Director, Business Excellence Wyeth |
 |
Huw Tippett,
Global Head of Sales Novartis |
|
|